[go: up one dir, main page]

IN2015DN01230A - Pyrrolopyrazoles as n type calcium channel blockers - Google Patents

Pyrrolopyrazoles as n type calcium channel blockers

Info

Publication number
IN2015DN01230A
IN2015DN01230A IN1230/DELNP/2015A IN1230DEN2015A IN2015DN01230A IN 2015DN01230 A IN2015DN01230 A IN 2015DN01230A IN 1230DEN2015 A IN1230DEN2015 A IN 1230DEN2015A IN 2015DN01230 A IN2015DN01230 A IN 2015DN01230A
Authority
IN
India
Prior art keywords
pyrrolopyrazoles
calcium channel
channel blockers
type calcium
compounds
Prior art date
Application number
IN1230/DELNP/2015A
Inventor
Michael P Winters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49170857&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN01230(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IN2015DN01230A publication Critical patent/IN2015DN01230A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and dis - orders, including pain. Such compounds are represented by Formula I as follows: Formula. (I) wherein R 1, R2 R3, Q, and G are defined herein.
IN1230/DELNP/2015A 2012-08-16 2015-02-16 Pyrrolopyrazoles as n type calcium channel blockers IN2015DN01230A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261683780P 2012-08-16 2012-08-16
PCT/US2013/055275 WO2014028805A1 (en) 2012-08-16 2013-08-16 Pyrrolopyrazoles as n-type calcium channel blockers

Publications (1)

Publication Number Publication Date
IN2015DN01230A true IN2015DN01230A (en) 2015-06-26

Family

ID=49170857

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1230/DELNP/2015A IN2015DN01230A (en) 2012-08-16 2015-02-16 Pyrrolopyrazoles as n type calcium channel blockers

Country Status (19)

Country Link
US (1) US8846949B2 (en)
EP (1) EP2885304B8 (en)
JP (1) JP6250674B2 (en)
KR (1) KR20150042271A (en)
CN (1) CN104936960B (en)
AU (1) AU2013302473B2 (en)
BR (1) BR112015003359A2 (en)
CA (1) CA2882127A1 (en)
CL (1) CL2015000359A1 (en)
CR (1) CR20150070A (en)
EA (1) EA201590379A1 (en)
ES (1) ES2607839T3 (en)
IL (1) IL237192A0 (en)
IN (1) IN2015DN01230A (en)
MX (1) MX2015002039A (en)
PE (1) PE20151139A1 (en)
PH (1) PH12015500310A1 (en)
SG (1) SG11201501133WA (en)
WO (1) WO2014028805A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9974775B2 (en) 2013-08-16 2018-05-22 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2882038A1 (en) 2012-08-16 2014-02-20 Janssen Pharmaceutica Nv Substituted pyrazoles as n-type calcium channel blockers
JP7141129B2 (en) * 2017-05-31 2022-09-22 ケモセントリックス，インコーポレイティド 5-5 Fused Rings as C5a Inhibitors
WO2018222598A1 (en) 2017-05-31 2018-12-06 Chemocentryx, Inc. 6-5 FUSED RINGS AS C5a INHIBITORS
CA3086111A1 (en) 2017-12-22 2019-06-27 Chemocentryx, Inc. Diaryl substituted 5,5-fused ring compounds as c5ar inhibitors
SG11202005791QA (en) 2017-12-22 2020-07-29 Chemocentryx Inc DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS
MX2020010390A (en) 2018-04-02 2021-01-15 Chemocentryx Inc PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS.
CN112300169B (en) * 2019-07-26 2022-03-04 上海美迪西生物医药股份有限公司 Pyrrolopyrazole derivatives, their preparation method and their application in medicine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1287174B1 (en) * 1996-11-15 1998-08-04 Angelini Ricerche Spa PHARMACOLOGICALLY ACTIVE DIARYL-CYCLOMETHYLENPYRAZOLES, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
JP2006522130A (en) * 2003-04-03 2006-09-28 メルク　エンド　カムパニー　インコーポレーテッド Biaryl-substituted pyrazoles as sodium channel blockers
US7145012B2 (en) * 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
NZ545836A (en) * 2003-09-17 2009-09-25 Janssen Pharmaceutica Nv Fused heterocyclic compounds as serotonin receptor modulators
FR2864958B1 (en) * 2004-01-12 2006-02-24 Sanofi Synthelabo N - [(1,5-DIPHENYL-1H-PYRAZOL-3-YL) METHYL] SULFONAMIDE DERIVATIVE, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
WO2005087750A1 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators
BRPI0508594A (en) * 2004-03-08 2007-08-21 Wyeth Corp ion channel modulators

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9974775B2 (en) 2013-08-16 2018-05-22 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers

Also Published As

Publication number Publication date
AU2013302473B2 (en) 2017-08-10
KR20150042271A (en) 2015-04-20
CR20150070A (en) 2015-05-18
IL237192A0 (en) 2015-04-30
CN104936960A (en) 2015-09-23
JP6250674B2 (en) 2017-12-20
EP2885304B8 (en) 2016-12-07
US8846949B2 (en) 2014-09-30
EP2885304B1 (en) 2016-09-21
PE20151139A1 (en) 2015-08-07
EP2885304A1 (en) 2015-06-24
WO2014028805A1 (en) 2014-02-20
ES2607839T3 (en) 2017-04-04
PH12015500310A1 (en) 2015-04-20
BR112015003359A2 (en) 2017-07-04
JP2015524853A (en) 2015-08-27
AU2013302473A1 (en) 2015-02-26
CN104936960B (en) 2016-12-28
CA2882127A1 (en) 2014-02-20
US20140051688A1 (en) 2014-02-20
MX2015002039A (en) 2016-01-22
SG11201501133WA (en) 2015-04-29
EA201590379A1 (en) 2015-06-30
CL2015000359A1 (en) 2015-04-24

Similar Documents

Publication Publication Date Title
PH12015500316A1 (en) Substituted pyrazoles as n-type calcium channel blockers
IN2015DN01230A (en) Pyrrolopyrazoles as n type calcium channel blockers
GEP201706695B (en) Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases
IN2015DN00960A (en)
IN2014DN09346A (en)
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
PH12014502624B1 (en) Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
MX2015007097A (en) Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer.
MX2014014531A (en) Aminoquinazoline and pyridopyrimidine derivatives.
PH12014500814A1 (en) New aryl-quinoline derivatives
PH12015500315A1 (en) Substituted pyrozales as n-type calcium channel blockers
MX2016001855A (en) Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection.
IN2012DN03846A (en)
PH12015500314B1 (en) Cyclopentylpyrazoles as n-type calcium channel blockers
MX2016002043A (en) Substituted imidazoles as n-type calcium channel blockers.
EA201591449A1 (en) METHODS OF OBTAINING TREATMENT COMPOSITIONS
MX2015007460A (en) Diazepine derivatives useful as calcium channel blockers in the treatment of pain.
PH12015502703A1 (en) Pharmaceutical compositions
MX2016001858A (en) Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection.
MX2014002343A (en) Parp inhibitors.